Literature DB >> 26951415

Objective Sleep Assessments in Patients with Postural Tachycardia Syndrome using Overnight Polysomnograms.

Kanika Bagai1,2, Amanda C Peltier1,2, Beth A Malow2, André Diedrich1,3,4,5, Cyndya A Shibao1,3, Bonnie K Black1,3, Sachin Y Paranjape1,3, Carlos Orozco1, Italo Biaggioni1,3,6, David Robertson1,2,3,6, Satish R Raj1,3,6,7.   

Abstract

STUDY
OBJECTIVES: Patients with postural tachycardia syndrome (POTS) commonly complain of fatigue, unrefreshing sleep, daytime sleepiness, and diminished quality of life. The study objective was to assess objective sleep quality in POTS patients using overnight polysomnography.
METHODS: We studied 16 patients with POTS and 15 healthy control subjects performing daytime autonomic functions tests and overnight polysomnography at the Vanderbilt Clinical Research Center.
RESULTS: There were no significant differences in the objective sleep parameters including sleep efficiency, sleep onset latency, wake time after sleep onset, REM latency, percentage of time spent in N1, N2, N3, and REM sleep, arousal index, apnea-hypopnea index, or periodic leg movement index in POTS patients as compared with healthy control subjects. There were significant negative correlations between sleep efficiency and the change in HR from supine to stand (rs = -0.527; p = 0.036).
CONCLUSIONS: POTS patients do not have significant differences in objective sleep parameters as compared to control subjects based on overnight polysomnograms. Activation of the sympathetic nervous system may contribute significantly to the hyper arousal state and worsening of subjective estimates of sleep quality as previously reported in POTS patients.
© 2016 American Academy of Sleep Medicine.

Entities:  

Keywords:  Postural Tachycardia Syndrome; hyperadrenergic; insomnia; norepinephrine; polysomnogram

Mesh:

Year:  2016        PMID: 26951415      PMCID: PMC4865560          DOI: 10.5664/jcsm.5806

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  27 in total

1.  Hypovolemia in syncope and orthostatic intolerance role of the renin-angiotensin system.

Authors:  G Jacob; D Robertson; R Mosqueda-Garcia; A C Ertl; R M Robertson; I Biaggioni
Journal:  Am J Med       Date:  1997-08       Impact factor: 4.965

2.  Functional neuroimaging evidence for hyperarousal in insomnia.

Authors:  Eric A Nofzinger; Daniel J Buysse; Anne Germain; Julie C Price; Jean M Miewald; David J Kupfer
Journal:  Am J Psychiatry       Date:  2004-11       Impact factor: 18.112

Review 3.  Postural tachycardia syndrome (POTS).

Authors:  Satish R Raj
Journal:  Circulation       Date:  2013-06-11       Impact factor: 29.690

4.  A survey-based analysis of symptoms in patients with postural orthostatic tachycardia syndrome.

Authors:  Anindita Deb; Karen Morgenshtern; Collin J Culbertson; Liz B Wang; Anna DePold Hohler
Journal:  Proc (Bayl Univ Med Cent)       Date:  2015-04

5.  The first night effect: an EEG study of sleep.

Authors:  H W Agnew; W B Webb; R L Williams
Journal:  Psychophysiology       Date:  1966-01       Impact factor: 4.016

6.  Sleep disturbances and diminished quality of life in postural tachycardia syndrome.

Authors:  Kanika Bagai; Yanna Song; John F Ling; Beth Malow; Bonnie K Black; Italo Biaggioni; David Robertson; Satish R Raj
Journal:  J Clin Sleep Med       Date:  2011-04-15       Impact factor: 4.062

7.  Chronic insomnia and activity of the stress system: a preliminary study.

Authors:  A N Vgontzas; C Tsigos; E O Bixler; C A Stratakis; K Zachman; A Kales; A Vela-Bueno; G P Chrousos
Journal:  J Psychosom Res       Date:  1998-07       Impact factor: 3.006

8.  Healthy older adults' sleep predicts all-cause mortality at 4 to 19 years of follow-up.

Authors:  Mary Amanda Dew; Carolyn C Hoch; Daniel J Buysse; Timothy H Monk; Amy E Begley; Patricia R Houck; Martica Hall; David J Kupfer; Charles F Reynolds
Journal:  Psychosom Med       Date:  2003 Jan-Feb       Impact factor: 4.312

9.  The hemodynamic and neurohumoral phenotype of postural tachycardia syndrome.

Authors:  E M Garland; S R Raj; B K Black; P A Harris; D Robertson
Journal:  Neurology       Date:  2007-08-21       Impact factor: 9.910

10.  Sleep disturbances and autonomic dysfunction in patients with postural orthostatic tachycardia syndrome.

Authors:  Julia Mallien; Stefan Isenmann; Anne Mrazek; Carl-Albrecht Haensch
Journal:  Front Neurol       Date:  2014-07-07       Impact factor: 4.003

View more
  6 in total

Review 1.  Cognitive and psychological issues in postural tachycardia syndrome.

Authors:  Vidya Raj; Morwenna Opie; Amy C Arnold
Journal:  Auton Neurosci       Date:  2018-03-27       Impact factor: 3.145

Review 2.  Autonomic regulation during sleep and wakefulness: a review with implications for defining the pathophysiology of neurological disorders.

Authors:  Anne M Fink; Ulf G Bronas; Michael W Calik
Journal:  Clin Auton Res       Date:  2018-08-28       Impact factor: 4.435

Review 3.  Pediatric Disorders of Orthostatic Intolerance.

Authors:  Julian M Stewart; Jeffrey R Boris; Gisela Chelimsky; Phillip R Fischer; John E Fortunato; Blair P Grubb; Geoffrey L Heyer; Imad T Jarjour; Marvin S Medow; Mohammed T Numan; Paolo T Pianosi; Wolfgang Singer; Sally Tarbell; Thomas C Chelimsky
Journal:  Pediatrics       Date:  2017-12-08       Impact factor: 7.124

Review 4.  Autonomic dysfunction in idiopathic hypersomnia: an overlooked association and potential management.

Authors:  Nour Adra; Manasa Reddy; Hrayr Attarian; Ashima S Sahni
Journal:  J Clin Sleep Med       Date:  2022-03-01       Impact factor: 4.062

5.  Restless legs syndrome is increased in postural orthostatic tachycardia syndrome.

Authors:  Caroline Dodson; Kanika Bagai; Leonard B Weinstock; Emily Thompson; Luis E Okamoto; Amanda Peltier; Satish R Raj; Arthur S Walters
Journal:  J Clin Sleep Med       Date:  2021-04-01       Impact factor: 4.062

6.  Sleep disturbance linked to suicidal ideation in postural orthostatic tachycardia syndrome.

Authors:  Cathy Lynn Pederson; Jill Blettner Brook
Journal:  Nat Sci Sleep       Date:  2017-04-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.